Patents by Inventor Kenji Tsunoda

Kenji Tsunoda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7673670
    Abstract: A semifinished joint plate 60 has a refrigerant inlet portion 45 and a refrigerant outlet portion 46 spaced apart in the front-rear direction. The semifinished plate 60 has an upwardly or downwardly extending slit 61 formed between the inlet portion 45 and the outlet portion 46, and slit width adjusting portions 62, 63 extending through the thickness of the plate 60, having a larger width than the slit 61 and communicating respectively with the upper and lower ends of the slit 61. A portion of the semifinished plate 60 above the upper adjusting portion 62 and a portion thereof below the lower adjusting portion 63 are bent to shorten the plate.
    Type: Grant
    Filed: March 8, 2005
    Date of Patent: March 9, 2010
    Assignee: Showa Denko K.K.
    Inventors: Naohisa Higashiyama, Kenji Tsunoda
  • Publication number: 20070215331
    Abstract: A semifinished joint plate 60 has a refrigerant inlet portion 45 and a refrigerant outlet portion 46 spaced apart in the front-rear direction. The semifinished plate 60 has an upwardly or downwardly extending slit 61 formed between the inlet portion 45 and the outlet portion 46, and slit width adjusting portions 62, 63 extending through the thickness of the plate 60, having a larger width than the slit 61 and communicating respectively with the upper and lower ends of the slit 61.
    Type: Application
    Filed: March 8, 2005
    Publication date: September 20, 2007
    Inventors: Naohisa Higashiyama, Kenji Tsunoda
  • Publication number: 20050215652
    Abstract: A process for continuously preparing a polyolefin foam molding, wherein expanded polyolefin resin beads are fed between a pair of upper and lower endless belts continuously traveling along a pair of opposing upper and lower surfaces, respectively, within a passage defined by structural members and rectangular in section, the expanded beads feed being then successively passed through a heating zone and a cooling zone within the passage. The expanded polyolefin resin beads have a core-coat structure in which the core is in an expanded state and comprises a crystalline polyolefin resin, while the coat is in a substantially unexpanded state and surrounds the core. The coat comprises a crystalline polyolefin polymer which is lower in melting point by at least 15° C. than that of the crystalline polyolefin resin or a substantially non-crystalline polyolefin polymer which is lower in Vicat softening point by at least 15° C. than that of the crystalline polyolefin resin.
    Type: Application
    Filed: March 22, 2005
    Publication date: September 29, 2005
    Applicant: JSP CORPORATION
    Inventors: Masanori Tanaka, Kenji Tsunoda
  • Patent number: 6231890
    Abstract: A suspension of a sparingly water-soluble acidic drug, especially, a nonsteroidal anti-inflammatory analgesic agent, which is stable for a prolonged period of time and is highly dissolvable, and a process for simply and easily producing the suspension. This suspension has a pH value of 2 to 5 and comprises a sparingly water-soluble acidic drug whose average particle size ranges from 1 to 15 &mgr;m, a polyglycerol fatty acid ester, a water-soluble polyhydric alcohol and water, optionally, together with an inorganic powder having an average particle size of 1 to 15 &mgr;m.
    Type: Grant
    Filed: October 22, 1998
    Date of Patent: May 15, 2001
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Mayumi Naito, Hiroshi Nakano, Kazuo Hasegawa, Toshiaki Nakajima, Ichiro Okudaira, Kenji Tsunoda
  • Patent number: 6057308
    Abstract: [Object] : To provide a pharmaceutical preparation for treating or preventing hyperlipemia which lowers cholesterols and neutral fats in blood and has a property to improve lipoprotein metabolism.[Construction] : A pharmaceutical preparation for treating or preventing hyperlipemia comprising taurine and .gamma.-oryzanol as effective components.
    Type: Grant
    Filed: November 17, 1998
    Date of Patent: May 2, 2000
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Hideaki Kitajima, Kenji Tsunoda, Teruyoshi Yanagita, Shigeru Murakami
  • Patent number: 6024984
    Abstract: A composition containing natural drugs is disclosed. The composition is effective for relieving physical and mental fatigue and for ameliorating a weakened constitution without any side effects, even if administered for a long time.
    Type: Grant
    Filed: June 4, 1998
    Date of Patent: February 15, 2000
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Masaaki Hanawa, Hideaki Kitajima, Kenji Tsunoda
  • Patent number: 5997852
    Abstract: A dermatitis-curing agent, characterized by comprising (A) a zinc compound and (B) at least one compound selected from the group consisting of multivalent unsaturated fatty acids and their esters as effective components is very effective for enteropathic acrodermatitis syndrome, and seborrheic dermatitis, psoriasis vulgaris, bullous dermatitis and puritus cutaneus, which show similar skin symptoms, or for symtoms due to zinc deficiency caused by injuries, burn injuries and frostbites.
    Type: Grant
    Filed: October 8, 1997
    Date of Patent: December 7, 1999
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Akiko Yoneda, Hideaki Kitajima, Kenji Tsunoda, Kazuo Hasegawa, Takako Ishii
  • Patent number: 5945121
    Abstract: Liposome eye drops contain taurine, glucose and inorganic salts having a pH of 5.5-8.0. The osmolarity is between 250 and 450 mOsm and at least a portion of the taurine and inorganic salts is encapsulated in the liposomes. A preferred embodiment also contains aspartate.
    Type: Grant
    Filed: May 15, 1997
    Date of Patent: August 31, 1999
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Muneyoshi Kato, Tomohiro Ohtsuki, Fuminobu Egami, Kenji Tsunoda
  • Patent number: 5824353
    Abstract: The cluster water having a potassium ion concentration of 100 ppm or more and containing potassium ions, magnesium ions and calcium ions in a weight ratio of potassium ions:magnesium ions:calcium ions of 1:0.3-4.5:0.5-8.5 has small clusters on the average, which are retained stably for a very long period of time at ordinary temperature.
    Type: Grant
    Filed: June 10, 1997
    Date of Patent: October 20, 1998
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Kenji Tsunoda, Kazumi Osada
  • Patent number: 4794106
    Abstract: An oil-in-water type cream comprising(a) 0.01 to 0.5% by weight of hydrocortisone butyrate proponate,(b) 5 to 50% by weight of a higher paraffinic hydrocarbon,(c) 3 to 15% by weight of a surface-active agent,(d) 30 to 65% by weight of purified water,(e) not more than 20% by weight of a monohydric higher alcohol,(f) not more than 20% by weight of a dihdyric or trihydric alcohol, and(g) a pharmaceutically acceptable acid in an amount required to adjust the pH of the cream to a value in the range of 3.5 to 6.5 when it is diluted with water to 20 times its volume.
    Type: Grant
    Filed: August 28, 1986
    Date of Patent: December 27, 1988
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Yasuji Takashima, Shigeo Tanaka, Kenji Tsunoda, Ichirou Kawamata, Hiroshi Murayama